Search clinical trials for: Bleeding events

Total 4149 results

Thomas Kander

Recruiting

Bleeding Events Before vs After Lowering Departmental Platelet Transfusion Trigger (OBS-PLATE)

Hematologic Diseases | Bleeding | Thrombocytopenia | Central Line Complication

Sweden
Institut universitaire de cardiologie et de pneumologie...

Not yet recruiting

Recurrent or Persistent Device Related Thrombus After Left Atrial Appendage Occlusion: The RE-DRT Study (RE-DRT)

Thromboembolic Event | Percutaneous Left Atrial Appendage Occlusion (LAAO) | Device-related Thrombus (DRT) | Major Cardioembolic Events | Major Bleeding - TIMI Classification
St. Antonius Hospital
ZonMw: The Netherlands Organisation for Health Research and Development; Pitié-Salpêtrière...

Recruiting

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation (POP ATLANTIS)

Severe Aortic Valve Stenosis

Netherlands
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE (ASTER)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Japan, Canada, Ireland, Italy, Korea, Republic of, France, Switzerland, Hungary, Netherlands, Latvia, Germany, Norway, Sweden, Czechia, United Kingdom
Anthos Therapeutics, Inc.
Itreas

Recruiting

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE (MAGNOLIA)

Venous Thromboembolism | Pulmonary Embolism | Deep Venous Thrombosis

Austria, United States, Taiwan, Australia, China, Spain, Korea, Republic of, Italy, Hungary, France, Netherlands, Latvia, Ireland, Germany, United Kingdom, Canada, Norway, Sweden, Czechia, Switzerland
American Thrombosis and Hemostasis Network
LFB USA, Inc.

Recruiting

SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors

Hemophilia A With Inhibitor | Hemophilia B With Inhibitor

United States
University of Southampton
University of Nottingham; Nottingham University Hospitals NHS Trust; East Kent... and other collaborators

Recruiting

Aspirin to Target Arterial Events in Chronic Kidney Disease (ATTACK)

Cardiovascular Diseases | Chronic Kidney Diseases | Bleeding

United Kingdom
Sanquin-LUMC J.J van Rood Center for Clinical Transfusion...

Recruiting

Bleeding In Thrombocytopenia Explained (BITE)

Hemorrhage | Hematologic Neoplasms | Bleeding | Platelet Transfusion

Netherlands
On-X Life Technologies, Inc.
North American Science Associates Inc.

Active, not recruiting

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

Thrombotic and Bleeding Events

United States, Canada, United Kingdom
Boston Scientific Corporation

Active, not recruiting

A Pilot Study to Assess WATCHMAN FLX™ Implants by Cardiac Computed Tomography, Magnetic Resonance Imaging and Transesophageal Echocardiography: WATCHMAN FLX™ CT

The Focus of the Study is to Reduce the Risk of Stroke and Life-threatening Bleeding Events in Patients With Non-valvular Atrial Fibrillation

Denmark
Anthos Therapeutics, Inc.
Laboratory Corporation of America; The TIMI Study Group

Active, not recruiting

Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation (AZALEA-TIMI 71)

Stroke | Atrial Fibrillation (AF)

United States, Canada, Czechia, Hungary, Korea, Republic of, Poland, Taiwan
argenx

Completed

A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP). (ADVANCE)

Primary Immune Thrombocytopenia

United States, Austria, Belgium, Bulgaria, Czechia, France, Georgia, Germany, Hungary, Italy, Japan, Netherlands, Poland, Russian Federation, Spain, Turkey, Ukraine, United Kingdom
Boehringer Ingelheim

Completed

A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin

Coronary Artery Disease | Atrial Fibrillation

Germany
IntraHealth International
Centers for Disease Control and Prevention; World Health Organization; Jhpiego; Ministry of Health, Tanzania and other collaborators

Completed

Evaluation of the Acceptability and Safety of the ShangRing Device for Male Circumcision in Shinyanga, Tanzania

Deformity | Penile Infection | Penile Haematoma | Penile Bleeding

Tanzania
Yonsei University

Active, not recruiting

A Randomized Comparison of CLOpidogrel Monotherapy Versus Extended Dual-antiplatelet Therapy Beyond 12 Months After Implantation of Drug-eluting StEnts in High-risk Lesions or Patients; A-CLOSE Trial

Coronary Artery Disease | DES

Korea, Republic of
Cipherome, Inc.
DHR Health Institute for Research and Development

Completed

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics (CARES2)

Myocardial Infarction | Ischemic Stroke | Thrombosis | Bleeding | Stent Thrombosis

United States
Sanofi

Active, not recruiting

Comparison of the Risk of Venous Thromboembolism (i.e., Blood Clots in the Veins) and Bleeding Events in a Population of Obese Patients Receiving Higher-Dose or Extended-Duration Versus Conventional-Dose or Conventional-Duration of Prophylaxis (i.e., Preventive Treatment) With Enoxaparin

Venous Thromboembolism

United States
Nationwide Children's Hospital

Completed

The Use of Ketorolac in Surgical Neonates

Postoperative Pain Control in Surgical Neonates

United States
Damascus University
Unipharma, HamaPharma, Almujtahed hospital

Completed

Rivaroxaban vs. Warfarin in CVT Treatment (RWCVT)

Cerebral Vein Thrombosis

Syrian Arab Republic
University of California, San Francisco
Patient-Centered Outcomes Research Institute; Kaiser Permanente

Completed

Anticoagulation Length of ThErapy and Risk of New Adverse evenTs In Venous thromboEmbolism Study (ALTERNATIVE)

Venous Thromboembolism | Anticoagulants and Bleeding Disorders

United States
Instituto Mexicano del Seguro Social

Completed

Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events

Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding | Venous Thromboses

Mexico
Karolinska Institutet
Aarhus University Hospital; Rigshospitalet, Denmark; Linkoeping University; Aalborg... and other collaborators

Completed

The Effect of Dexamethasone 12 mg vs 6 mg on Thromboembolic Events in Patients With Critical COVID-19

COVID-19 | Bleeding | Thrombosis Embolism

Sweden
AstraZeneca

Completed

Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical Practice (ALETHEIA)

Myocardial Infarction (MI)

Sweden, United Kingdom, United States, Italy, Germany
CSL Behring
Kaiser Permanente

Completed

An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding

Hemorrhage

United States
Hennepin Healthcare Research Institute
National Health and Medical Research Council, Australia; National Cancer Institute... and other collaborators

Active, not recruiting

Aspirin in Reducing Events in the Elderly (ASPREE)

Depression | Stroke | Cancer | Bleeding | Dementia | Heart Disease | Functional Disability

United States, Australia
University Hospital, Strasbourg, France

Completed

Thrombin Generation as a New Test for Anticoagulation Management in Patients With ECMO (ECMOstase)

Implantation of a Veno-arterial or Veno-venous ECMO

France
Rigshospitalet, Denmark

Completed

Frequency of Vascular Events With Short-term Thromboprophylaxis in Fast-track Hip and Knee-arthroplasty. (FETA)

Thromboembolic Events | Post-operative Bleeding

Denmark
Ohio State University

Completed

Comparison of Blood Product Use and Bleeding Events During and After Endoscopic or Neurosurgical Procedures in Patients With Cirrhosis and Coagulopathy (SCARLET)

Cirrhosis | Coagulopathy
Saranas, Inc.
Proxima Clinical Research; Medical Metrics Diagnostics, Inc

Completed

Safety and Accuracy of the Saranas EBBMS for the Detection of Endovascular Procedure Related Bleeding Events

Endovascular Procedures

United States
Atrial Fibrillation Network

Completed

Prospective Registration and Assessment of Serious Adverse Events Within the AFNET (AFNET A7)

Atrial Fibrillation | Assessment of Serious Advers Events | Thromboembolic and Bleeding Complications | Complications of Antiarrhythmic Drugs or Invasive Procedures | Assessment by a Critical Event Committee

Germany
University of Utah
Stanford University

Completed

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

Venous Thromboembolism | Deep Venous Thrombosis | Pulmonary Embolus | Reconstructive Surgery

United States
Assistance Publique - Hôpitaux de Paris
Bristol-Myers Squibb; Daiichi Sankyo, Inc.

Terminated

Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology (PRADICO)

Invasive Procedure | Oral Anticoagulants

France
Karolinska Institutet

Completed

Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients

Covid-19 | Bleeding | Thromboembolic Events

Sweden
Academisch Medisch Centrum - Universiteit van Amsterdam...

Completed

Venous Thromboembolism and Bleeding Risk in Patients With Esophageal Cancer (VENETIA)

Bleeding | Venous Thromboembolism | Chemotherapy Effect | Esophagus Cancer

Netherlands
Universitätsmedizin Mannheim

Completed

Femoral Closure Versus Radial Compression Devices Related to Percutaneous Coronary Interventions Study (FERARI)

Percutaneous Coronary Intervention (PCI) | Arterial Closure Device | Access Site Bleeding | Adverse Cardiac Events

Germany
Assistance Publique - Hôpitaux de Paris

Unknown

Endothelial Activation Hemostasis Disturbances and Severe Bleeding Events in Hyperleukocytic Acute Myeloid Leukemia (HEAL)

Leukemia, Myeloid, Acute
Azienda Ospedaliero-Universitaria Consorziale Policlinico...
Prof. Carlo Manno; Dott. Francesco Pesce; Dott. Michele Rossini; Dott. Vincenzo...

Unknown

Correlation Between Platelet Function Analyzer-100 Testing and Bleeding Events After Percutaneous Kidney Biopsy

Kidney Diseases | Hemorrhage | Blood Platelet Disorder

Italy
Helios Albert-Schweitzer-Klinik Northeim

Unknown

Endoscopic Sphincterotomy vs. Balloon Dilation for Assessment of Pancreatitis

Pancreatitis

Germany
Xiaofan Wu

Unknown

Efficacy and Safety of Low Dose Ticagrelor in Patients With Unstable Angina Pectoris After Coronary Stent Implantation

Unstable Angina Pectoris | Coronary Stent Implantation

China
Chinese PLA General Hospital

Unknown

Effectiveness of Artificial Intelligent Based mHealth System to Reduce ACS Patients Bleeding Events After PCI

Bleeding | Acute Coronary Syndrome | Percutaneous Coronary Intervention

China
Bayer

Completed

Epidemiological Study on the Safety of Aspirin in The Health Improvement Network (THIN) (EPISAT)

Stroke | Coronary Heart Disease | Ischemic Heart Disease | Secondary Prevention

United Kingdom
Bristol-Myers Squibb
Pfizer

Withdrawn

Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation

Non-valvular Atrial Fibrillation
Central Hospital, Nancy, France

Unknown

Bleeding Events After Triple Antithrombotic Therapy Initiation. (HEMOTRI)

Bleeding
Baim Institute for Clinical Research
Bristol-Myers Squibb; Eli Lilly and Company; Daiichi Sankyo, Inc.; Boston Scientific... and other collaborators

Completed

The Dual Antiplatelet Therapy Study (DAPT Study)

Coronary Artery Disease

United States, Australia, Czechia, New Zealand, United Kingdom, Germany, Hungary, Poland, France, Romania
Universitätsklinikum Hamburg-Eppendorf

Completed

Low-dose Acetylsalicylic Acid Before Non-cardiac Surgery

Surgery | Platelet Dysfunction

Germany
General Hospital of Chinese Armed Police Forces

Completed

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Non ST Segment Elevation Acute Coronary Syndrome

China
David Antoniucci
A.R. CARD Onlus Foundation

Terminated

BLeeding Events and Maintenance DoSe of PraSugrel (BLESS)

Acute Coronary Syndrome | Adverse Reaction to Antiplatelet Agent

Italy
Seoul St. Mary's Hospital
AstraZeneca; The Catholic University of Korea; Chonnam National University

Unknown

CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction II (COREA-AMI II)

Bleeding | Percutaneous Coronary Intervention | Acute Myocardial Infarction | Major Adverse Cardiovascular Events

Korea, Republic of
Boehringer Ingelheim

Completed

Management of Major Bleeding Events in Atrial Fibrillation Patients Using Pradaxa

Hemorrhage | Atrial Fibrillation

United States
AstraZeneca

Completed

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout

Sweden

Search clinical trials for: Bleeding events

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations